Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. Other stock markets 10/08/2026			5-day change	1st Jan Change
14.22 ^MXN	-0.97%		-2.74%	-20.51%

07-24	Genomma Lab Internacional, S.A.B. de C.V., Q2 2026 Earnings Call, Jul 23, 2026
07-23	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	13,865	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-20.65%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	18,318	17,424	16,702
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-17.64%	-4.88%	-4.14%
P/E	14.9x	12x	13.1x	11.7x	11.1x	5.55x	6.67x	5.86x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	0.98x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.1x	-0.4x	0.4x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.74x	0.72x	0.68x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	0.98x	0.91x	0.82x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	4.02x	3.92x	3.52x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.36x	4.3x	3.86x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	16.5x	8.54x	7.21x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	6.04%	11.7%	13.9%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8342	1.232	1.585
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	5.87%	8.66%	11.1%
EPS ²	1.44	1.41	1.08	2.14	1.61	2.56	2.132	2.425
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	32.6%	57.8%	65.4%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	18,724	19,192	20,345
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,558	4,448	4,745
EBIT ¹	3,063	3,263	3,224	3,982	3,760	4,198	4,052	4,328
Net income ¹	1,451	1,397	1,031	2,137	1,607	2,194	2,177	2,457
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,453	3,559	2,837
Reference price ²	21.48	16.94	14.16	25.13	17.89	14.22	14.22	14.22
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	975,033	-	-
Announcement Date	23/02/22	22/02/23	21/02/24	26/02/25	25/02/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	5.55x	0.98x	4.02x	5.87%	809M
ELI LILLY AND COMPANY	34.93x	12.78x	25.81x	0.56%	1,098B
JOHNSON & JOHNSON	29.12x	-	-	2.05%	631B
ABBVIE INC.	31.66x	7.38x	15.33x	2.77%	438B
ROCHE HOLDING AG	20.79x	4.93x	12.21x	2.68%	368B
NOVARTIS AG	22.24x	5.75x	14.34x	2.79%	298B
ASTRAZENECA PLC	20.77x	4.28x	12.16x	2.05%	251B
AMGEN INC.	26.18x	6.87x	12.22x	2.42%	226B
NOVO NORDISK A/S	13.88x	4.98x	10.54x	3.66%	209B
GILEAD SCIENCES, INC.	-41.32x	5.92x	33.42x	2.48%	165B
Average	16.38x	5.98x	15.56x	2.73%	368.51B
Weighted average by Cap.	24.99x	8.33x	18.78x	1.95%